GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹611 Cr | ₹1,695 Cr |
What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1,036 Cr |
| Mar2025 | ₹928 Cr |
| Mar2024 | ₹590 Cr |
| Mar2023 | ₹611 Cr |
| Mar2022 | ₹1,695 Cr |
How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,036 Cr | 11.69 | |
| Mar2025 | ₹928 Cr | 57.23 | |
| Mar2024 | ₹590 Cr | -3.39 | |
| Mar2023 | ₹611 Cr | -63.97 | |
| Mar2022 | ₹1,695 Cr | - | |
Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹48,727.9 Cr | 2.7% | -1.8% | 5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.7% |
-1.8% |
5% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses